(Bloomberg) -- AbbVie Inc.’s Chief Executive Officer Richard A. Gonzalez will retire after a colorful tenure that included the multibillion takeover of Botox-maker Allergan as he raced to wean ...

AbbVie said longtime executive Robert Michael will become the company's new CEO, replacing Richard Gonzalez. Michael, who is ...

AbbVie’s CEO Richard Gonzalez took a huge bet that Rova-T would be the next big thing in oncology. Rova-T had a convincing-looking mechanism of action, consisting of an antibody that locks onto ...

If it does prove to be the end of emraclidine for schizophrenia, that looks set to benefit Bristol-Myers Squibb, which ended ...

In a report released today, Srikripa Devarakonda from Truist Financial maintained a Buy rating on AbbVie (ABBV – Research Report). The ...

In a report released yesterday, Louise Chen from Cantor Fitzgerald maintained a Buy rating on AbbVie (ABBV – Research Report), with a ...